Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05108220 · ClinicalTrials.gov registry record
Evaluation of Effects of CBD Products on Anxiety Among U.S. Women
A clinical trial, sponsored by Radicle Science.
- Completed
- Registry status
- 1,350
- Enrollment target
NCT05108220: Completed study, sponsored by Radicle Science.
NCT05108220 is a clinical trial that has completed, run by Radicle Science. The registered enrollment target is 1,350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05108220 has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- 1,350 participants
- Enrollment target
Study Summary
The investigators will conduct a retrospective cohort analysis of a consumer trial conducted by Rae Wellness. The trial took place between October 15, 2020 and December 30, 2020 and involved 1350 U.S. women who used in-home use tests (IHUT) of various Cannabidiol (CBD) products. Participants were randomized to one of 9 groups: 8 groups received one of 8 different CBD products in the mail, and one group served as the control and did not consume any CBD product. The CBD products varied by method of delivery, concentration of Tetrahydrocannabinol (THC), and dosage of CBD. Participants were asked to use the product once daily for 60 day and to complete health questionnaires at baseline, 30 days and 60 days.
Primary Outcome
Anxiety score, according to the Generalized Anxiety Disorder (GAD)-7 scale. Scores range from 0 to 21, with higher scores representing more severe anxiety.
Interventions
- DIETARY_SUPPLEMENT Cannabidiol (CBD)- containing consumer products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2020-12-30 |
What the finished NCT05108220 record still lists
NCT05108220 is an observational study that tracks outcomes without assigning an intervention. Its 1,350 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Cannabidiol (CBD)- containing consumer products is the first listed.
NCT05108220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05108220 about?
NCT05108220 is a clinical study titled "Evaluation of Effects of CBD Products on Anxiety Among U.S. Women". The investigators will conduct a retrospective cohort analysis of a consumer trial conducted by Rae Wellness. The trial took place between October 15, 2020 and December 30, 2020 and involved 1350 U.S. women who used in-home use tests (IHUT) of various Cannabidiol (CBD) products. Participants were ra...
What is the current status of trial NCT05108220?
This trial is currently completed. The enrollment target is 1,350 participants. The study started on 2020-10-15. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT05108220?
The interventions under investigation include: Cannabidiol (CBD)- containing consumer products (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05108220?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI